BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11562580)

  • 1. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting.
    Mirow N; Minami K; Kleikamp G; Tenderich G; Puhlmann T; Körfer R
    Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Kleesiek K; Körfer R
    Artif Organs; 2001 Jun; 25(6):480-5. PubMed ID: 11453879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N; Zittermann A; Koertke H; Maleszka A; Knobl H; Coskun T; Kleesiek K; Koerfer R
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
    Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization.
    Mirow N; Zittermann A; Körperich H; Börgermann J; Koertke H; Knobl H; Gieseke J; Ostertun B; Coskun T; Kleesiek K; Burchert W; Gummert JF
    J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
    ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.
    Ranucci M; Cazzaniga A; Soro G; Isgrò G; Frigiola A; Menicanti L
    J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):316-20. PubMed ID: 12073203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.
    Ranucci M; Pazzaglia A; Isgrò G; Cazzaniga A; Ditta A; Boncilli A; Cotza M; Carboni G; Brozzi S; Bonifazi C
    Int J Artif Organs; 2002 Sep; 25(9):875-81. PubMed ID: 12403404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
    Suehiro S; Shibata T; Sasaki Y; Hattori K; Kumano H; Hosono M; Kinoshita H
    Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.